TITLE

Critical Care Therapeutics

AUTHOR(S)
Birrer, Kara L.; Cat, Tram; Hall, Lisa; Patanwala, Asad
PUB. DATE
May 2007
SOURCE
Hospital Pharmacy;May2007, Vol. 42 Issue 5, p411
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the impact of pharmacologic interventions on the treatment of the critically ill patient. It cites the findings of studies conducted on the use of hypertonic saline solution (HSS) on patients with traumatic brain injuries. It explores the role of antibiotics in open fractures. It details the guidelines pertaining to the use of sedatives in critically ill patients developed by the Society of Critical Care Medicine and American Society of Health-System Pharmacists.
ACCESSION #
25167199

 

Related Articles

  • Therapeutic Mild Hypothermia and the Pharmacokinetics of Drugs in Trauma Brain Injury (TBI) Patients with a Focus on Sedation, Anticonvulsant and Antibiotic Therapy. Bagna, F. Carlotta; Pitoni, Sara; Andrews, Peter J. D. // Open Critical Care Medicine Journal;2013, Vol. 6, p31 

    Background: Therapeutic hypothermia may alter both the pharmacokinetic (PK) and dynamics (PD) of the commonly used drugs in critical care. To achieve maximum benefit, medication dosage and schedules should be optimized. Objective: To review the existing scientific evidence showing the effect of...

  • Sedation in Traumatic Brain Injury. Flower, Oliver; Hellings, Simon // Emergency Medicine International;2012, p1 

    Several different classes of sedative agents are used in the management of patients with traumatic brain injury (TBI). These agents are used at induction of anaesthesia, to maintain sedation, to reduce elevated intracranial pressure, to terminate seizure activity and facilitate ventilation. The...

  • Decompressive craniectomy in traumatic brain injury - time for randomised trials? Hutchinson, P. J.; Menon, D. K.; Kirkpatrick, P. J. // Acta Neurochirurgica;Jan2005, Vol. 147 Issue 1, p1 

    The article presents information about decompressive craniectomy in traumatic brain injury. Decompressive craniectomy have potential advantages over other neuro-protective therapies. It has a global action not restricted to one metabolic pathway and it is unlikely to suffer from the systemic...

  • Dexmedetomidine.  // Reactions Weekly;6/14/2008, Issue 1206, p11 

    The article describes the case of a 32-month-old boy who developed hypertension after receiving dexmedetomidine for sedation after a traumatic brain injury. Patient was involved in a motor vehicle accident and was given dexmedetomidine to control his agitation. After a day, the patient developed...

  • Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury. Guan, Jian // Recent Patents on CNS Drug Discovery;Jun2008, Vol. 3 Issue 2, p112 

    Brain ischemia induces the IGF-1 system in damaged regions, and exogenous administration of IGF-1 after injury is neuroprotective and improves long-term neurological function. The short treatment window can be extended by mild hypothermia, probably due to delayed apoptosis. Nevertheless, the...

  • Pharmacological Treatment of Traumatic Brain Injury: A Review of Agents in Development. Hatton, J. // CNS Drugs;2001, Vol. 15 Issue 7, p553 

    Successful treatment strategies for patients with traumatic brain injury (TBI) remain elusive despite standardised clinical treatment guidelines, improved understanding of mechanisms of cellular response to trauma, and a decade of clinical trials aimed at identifying therapeutic agents targeted...

  • Pharmacological Strategies for Neuroprotection in Traumatic Brain Injury. Jennings, J. S.; Gerber, A. M.; Vallano, M. L. // Mini Reviews in Medicinal Chemistry;Jun2008, Vol. 8 Issue 7, p689 

    Traumatic brain injury affects over a million Americans annually, but pharmacological therapy remains limited. Current standards of care in acute, subacute and chronic phases of injury are primarily supportive. This review discusses pharmacological strategies and future directions in patient...

  • Pharmacological Manipulation of Neural Progenitor Pathways In Situ: Possibilities for Neural Restoration in the Injured Adult Brain. Mellough, Carla B.; Wood, Andrew; Przyborski, Stefan A. // Current Medicinal Chemistry - Central Nervous System Agents;Mar2005, Vol. 5 Issue 1, p67 

    Progress over the last decade has confirmed the occurrence of de novo neurogenesis within discrete regions of the adult brain. It has been demonstrated that under certain conditions neurogenesis can be stimulated above basal levels in the adult, and that resident pools of adult progenitors can...

  • Hypothermia in trauma victims - friend or foe? Søreide, Eldar; Smith, Charles E. // Indian Journal of Critical Care Medicine;Apr-Jun2004, Vol. 8 Issue 2, p116 

    Hypothermia often complicates the management of patients with severe blunt or penetrating injury, and has been associated with increased morbidity and mortality. Early control of bleeding and prevention of further heat loss are key factors to avoid the lethal triad of hypothermia, acidosis and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics